Treating Calciphylaxis with HBOT In the realm of medical breakthroughs, there are few treatments as remarkable as hyperbaric oxygen therapy (HBOT). With its ability to harness the healing potential of oxygen, HBOT has emerged as a groundbreaking approach for numerous...
Kidney Disease
Explore the latest research on the use of Hyperbaric Oxygen Therapy (HBOT) to treat Kidney Disease. Extivita maintains an extensive publication database for Kidney Disease and various other indications with therapies such as Hyperbaric Oxygen Therapy, Neurofeedback, Nutritional IV Therapy, Infrared Sauna, and Pulsed Electromagnetic Field Therapy. Explore our database on Acne and Hyperbaric Oxygen Therapy aka, HBOT, below.
For a complete list of indications treated at Extivita, explore the conditions we treat.
Nicolas Colsaerts: Who knows what the future holds for the new version of myself
Dubai: Belgian golfer Nicolas Colsaerts, who is on a recovery path from rare kidney disease, is eager to come back on the Tour as quickly as possible. The 10-time champion says he has missed his job and passion badly for the last six months and is ready to fire on all...
Early diagnosis, prevention and treatment for calcific uremic arteriolopathy.
Abstract: Calcific uremic arteriopathy (CUA), termed calciphylaxis, is a rare but highly fatal clinical syndrome. There is no clearly laboratory diagnostic criteria for CUA. The medium and small arterial calcification and microthrombosis discovered by skin biopsy,...
Might hyperbaric oxygen therapy (HBOT) reduce renal injury in diabetic people with diabetes mellitus? From preclinical models to human metabolomics.
Diabetic kidney disease (DKD) is the leading cause of end-stage renal failure in the western world. Current treatment of diabetic kidney disease relies on nutritional management and drug therapies to achieve metabolic control. Here, we discuss the potential application of hyperbaric oxygen therapy (HBOT) for the treatment of diabetic kidney disease (DKD), a treatment which requires patients to breathe in 100% oxygen at elevated ambient pressures. HBOT has traditionally been used to diabetic foot ulcers (DFU) refractory to conventional medical treatments. Successful clinic responses seen in the DFU provide the underlying therapeutic rationale for testing HBOT in the setting of DKD. Both the DFU and DKD have microvascular endothelial disease as a common underlying pathologic feature.